How Discovery Fast Track works

Questions to ask before you enter:

Do you have a clear therapeutic hypothesis?

We are looking for a coherent and supportable hypothesis to develop a medicine that would provide therapeutic benefit to particular groups of patients.

Do you have a defined target?

You should have identified a specific protein drug target linked to a disease and be able to propose why modulating this target with a small molecule could provide an effective and safe therapy.

Do you have enabling expertise?

The 2018 Discovery Fast Track Australian Challenge is a collaboration. You should have generated data which provides proof of concept for your proposal and, ideally, already have developed key reagents and assays.

If you answered “yes” to the above questions, then the 2018 Discovery Fast Track Australian Challenge is a great opportunity for you. If you wish to propose a biological as a therapeutic, you may want to reach out to GSK’s Discovery Partnerships with Academia (DPAc) team. If you wish to propose a vaccine, technology or delivery system, see these other opportunities at GSK Partnerships. For proposals centred on tropical diseases, explore our partnerships for neglected tropical diseases.

Workflow for 2018 Discovery Fast Track Australian Challenge

chart: Workflow for 2018 Discovery Fast Track Australian Challenge

The submission process.

To get started, create your Discovery Fast Track account.